View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Haupt Pharma
30 September 2008

Norbert Schwella Appointed Chief Financial Officer (CFO) of Haupt Pharma

Mr Norbert Schwella has been appointed as the chief financial officer (CFO) and a member of the extended executive board of Haupt Pharma.

The function of the CFO was created with regard to the increasing tasks and responsibilities to be handled with the integration of AMAREG and Wülfing Pharma. The CFO will be responsible for accounting, controlling, treasury and IT within the group.

Mr Schwella was born in 1947 in Wiesbaden. He graduated as an economist from the University of Bonn and in the course of his professional career has gained extensive experiences as managing director and CFO in companies such as Brau & Brunnen and Amoco Chemical.

Furthermore, Mr Schwella worked as a self-employed interim manager at Pitney Bowes Germany and in the automobile industry. In 2007, Mr Schwella became managing director of allegropharm, where he was responsible for the commercial sector of AMAREG and Wülfing Pharma.

Haupt Pharma is one of the leading contract developers and manufacturers for pharmaceutical products in Europe.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology